Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report

• Asıl Yazarlar: Boney Joseph (Yazar), Nicolas A. Nunez (Yazar), Simon Kung (Yazar), Jennifer L. Vande Voort (Yazar), Vanessa K. Pazdernik (Yazar), Kathryn M. Schak (Yazar), Stacey M. Boehm (Yazar), Brooke Carpenter (Yazar), Emily K. Johnson (Yazar), Grigoriy Malyshev (Yazar), Nathan Smits (Yazar), Daniel O. Adewunmi (Yazar), Sarah K. Brown (Yazar), Balwinder Singh (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2023-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Intravenous (IV) ketamine and FDA-approved intranasal (IN) esketamine are increasingly used for treatment-resistant depression (TRD). Preliminary studies have suggested a synergistic effect of ketamine and lamotrigine, although the data are inconclusive. Herein, we report the response to serial keta...